$9.76
0.141.46%
At close: -
$9.60
-0.16-1.64%
After Hours: 7:18 AM EDT
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)
Ticker | Name | Share % | |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc. | 5.66% | |
RNA | Avidity Biosciences Inc | 5.52% | |
TECH | Bio-Techne Corp | 4.41% | |
LEGN | Legend Biotech Corp | 4.29% | |
ARWR | Arrowhead Pharmaceuticals Inc | 4.22% | |
NTLA | Intellia Therapeutics Inc | 4.19% | |
MYGN | Myriad Genetics Inc | 4.08% | |
SRPT | Sarepta Therapeutics Inc | 3.94% | |
NTRA | Natera Inc | 3.84% | |
MRNA | Moderna Inc | 3.76% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
GNOM follows a Mid Cap Growth investment style.
The top holdings of GNOM include: ALNY (5.66%), RNA (5.52%), TECH (4.41%), LEGN (4.29%), ARWR (4.22%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for GNOM is currently not available.